Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2010

View Archived Issues

Denufosol improves lung function in patients with cystic fibrosis

Lixivaptan evaluated vs. furosemide in healthy volunteers

Tirofiban shows safety/preliminary efficacy in BAO and stroke

Merck & Co. claims new neuropeptide S receptor antagonists

New immunoprophylactic antibacterial CLDC+MPF combination presented

Aclidinium bromide shows preliminary efficacy in COPD

NeuroSearch discloses new GABA(A) receptor modulators

Lilly claims new hedgehog signaling inhibitors

New FABP inhibitors presented

MDX-1097 is evaluated in phase I trial in multiple myeloma

Phase I trial data presented on GSK-923295 in solid tumors

GlaxoSmithKline discloses highlights of first quarter 2010

PolyMedix completes phase Ib trial of PMX-60056 for reversal of heparin action

Ascenta and sanofi-aventis sign license agreement in oncology

Scancell and ImmuneRegen BioSciences form strategic alliance

H4 receptor antagonist UR-63325 yields favorable first-in-human data

AstraZeneca submits Axanum MAA in E.U.

Bausch and Lomb acquires Zirgan ophthalmic gel from Sirion

TauRx and Bayer Schering enter into AD collaboration

Preliminary phase III data reported on oral insulin spray

Janssen expands licensing agreement for tapentadol

FDA grants orphan drug status to GVAX CML vaccine

CombinatoRx receives milestone payment for Prednisporin

Grifols to acquire Talecris Biotherapeutics

TK therapy R&D project receives grant from Regione Lombardia

FDA accepts DM-1796 NDA for postherpetic neuralgia

Phase III trial of plitidepsin initiated in multiple myeloma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...